This message was sent to ##Email##
|
|
|
|
|
| |
The JAMA Network
Application of deep learning algorithms to whole-slide pathology images can potentially improve diagnostic accuracy and efficiency. Assess the performance of automated deep learning algorithms at detecting metastases in hematoxylin and eosin–stained tissue sections of lymph nodes of women with breast cancer and compare it with pathologists’ diagnoses in a diagnostic setting.
READ MORE
ACS Cancer Programs
The Commission on Cancer (CoC) announced that effective December 11, 2017, the percentage of delivered survivorship care plans to eligible patients required for CoC compliance with Standard 3.3 has been lowered to 50 percent for 2018. All CoC-accredited programs will be expected to meet or exceed the delivery of survivorship care plans to 50 percent of eligible patients by the end of 2018. This announcement replaces the current language on page 59 of the Cancer Program Standards: Ensuring Patient-Centered Care (2016 edition) that required the delivery of survivorship care plans to 75 percent of eligible patients for 2018.
Additional revisions to CoC Standard 3.3 will be announced in the first quarter of 2018 but will not go into effect until January 1, 2019. All CoC-related questions should be submitted to the CAnswer Forum.
All centers accredited by National Accreditation Program for Breast Centers (NAPBC) will also be expected to meet or exceed the delivery of survivorship care plans to 50 percent of eligible patients by the end of 2017 and beyond as stated in Standard 2.20 of the 2018 National Accreditation Program for Breast Centers Standards Manual that goes into effect April 1, 2018. Please forward all questions regarding the NAPBC standards to napbc@facs.org.
READ MORE
Institute for Research in Biomedicine (IRB Barcelona) via ScienceDaily
In most cases, prostate cancer is cured by surgical removal of the tumor and/or by radiotherapy. However, 20 percent of patients will need treatment to remove tumor cells but this treatment ceases to be effective after two or three years and the cancer develops further. Once this stage of the disease has been reached, there is no cure. A team headed by Xavier Salvatella, ICREA researcher at the Institute for Research in Biomedicine, has discovered a new avenue through which to attack prostate cancer cells that have developed drug-resistance.
READ MORE
ACS CRP
The American College of Surgeons (ACS) Clinical Research Program (CRP) invites you to attend a live webinar on Wednesday, January 10 from 10:00 to 11:00 am (CST) that will provide an update on Ongoing Breast Cancer Cooperative Group Clinical Trials. The webinar will focus on A11106 (Alternate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant Treatment [ALTERNATE] in postmenopausal women) and AFT-25 (Comparison of Operative to Monitoring and choice of Endocrine Therapy [COMET] Trial for Low Risk DCIS: A Phase III Prospective Randomized Trial). Register today.
READ MORE
The Journal of the American College of Surgeons
Breast cancer is the second most common cancer among women in the United States, with more than 230,000 women diagnosed annually. (Skin cancer remains the most common.) Patients often describe the process of making a treatment decision as worrisome, so one research team wanted to explore how these patients became informed about their treatment options, and why some women might feel less than completely informed.
READ MORE
|
Promoted by
|
|
|
|
 |
ACS Cancer Programs
Beginning January 1, 2018, both the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC) are introducing new annual Accreditation fees.
The CoC fees are now based on the accreditation category assigned to the program. CoC-accredited programs will find information about the fees, descriptions of cancer program categories and a fee-related frequently asked questions document on the CoC Datalinks menu. Please
access CoC Datalinks and log in using your Datalinks username and password. For assistance with your username and password, please e-mail CoCDatalinks@facs.org. For questions about fees and CoC invoices, please e-mail accreditation@facs.org.
To obtain information on the 2018 fees for the National Accreditation Program for Breast Centers (NAPBC), please go to the NAPBC portal.For assistance with the NAPBC portal, please contact your center’s Breast Program Director or another staff member with NAPBC center portal access to manage your center portal authorized users . For questions about NAPBC fees and invoices, please e-mail nabpc@facs.org.
READ MORE
The Medical News
Like nomads who carry tokens of home on their travels, colorectal cancer cells that spread to other parts of the body appear to bring several of the species of bacteria that were their companions in the colon, Dana-Farber Cancer Institute scientists report in a new study in the journal Science. The findings are the latest evidence that the microbiome — the menagerie of microorganisms in the body — may play a role in colon cancer growth and could offer a new avenue for treatment of the disease, researchers say.
READ MORE
Georgia State University via Medical Xpress
A blood test using infrared spectroscopy can be used to diagnose two types of cancer, lymphoma and melanoma, according to a study led by Georgia State University. Researchers used mid-infrared spectroscopy to analyze blood serum derived from experimental mice and differentiate mice with non-Hodgkin's lymphoma and subcutaneous melanoma from healthy mice and also between these 2 tumorous conditions. The mid-infrared spectral region of the electromagnetic spectrum is frequently used to characterize biological samples at the molecular level.
READ MORE
ACS Quality Programs
The 2018 ACS Quality and Safety Conference: Partners in Quality will be held in Orlando, July 21-24. This education program brings health care professionals together to discuss and apply current knowledge pertaining to national and local quality initiatives in the field of surgery. Attendees will learn techniques to manage, analyze and interpret data to make a positive impact at their facilities. The Cancer Programs are excited to be included in this one-of-a-kind conference and encourage staff working in CoC — and/or NAPBC-accredited programs to submit an abstract for a podium or poster presentation. The abstract should relate to surgical quality improvement initiatives, including the development, implementation or validation of best practices within your accredited program. Abstracts for this conference will be accepted until Jan. 26, 2018. (Please note: This is not the 2018 Cancer Program Annual Conference that will be held in the fall of 2018. Information on the 2018 Cancer Programs Annual Conference will be available in early January 2018.)
READ MORE
| |
PRODUCT SHOWCASE | Advertisement
|
 |
|
Enjoy our journals? There’s an app for those! Journals such as those from the American Cancer Society ™, Journal of Surgical Oncology, Cancer Science and more are now available for your iPad and iPhone. Sample issues and abstracts, as well as open articles, can be accessed for free. A subscription to the journal is required to read the full text. Click here to learn more!
|
|
ACS-AJCC
The American Joint Committee on Cancer (AJCC) will be conducting a number of webinars on the AJCC Cancer Staging Manual, Eighth Edition in 2018. The webinars are scheduled as follows: Feb. 15, 2018 - Minor Rule Changes; March 20, 2018 - Major Rule Changes; April 17, 2018 - CAnswer Forum and Staging Questions; July 25, 2018 - Head and Neck Staging; and Sept. 6, 2018 - Breast Staging. All webinars will be held from 1:00 to 2:00 pm CT. Make sure to mark your calendars. Visit the AJCC website for updates, additional information and registration links.
READ MORE
Healio
Patients with a high fatty liver index, a noninvasive method used to predict non-alcoholic fatty liver disease, showed a higher risk for colorectal adenomas, according to new research.
Investigators concluded that the fatty liver index may therefore be useful for predicting the presence of colorectal adenomas, which are considered “the GI manifestation of metabolic syndrome.”
READ MORE
The Medical News
Researchers from Instituto de Medicina Molecular (iMM) João Lobo Antunes have found a mechanism through which certain types of leukemia resist chemotherapy, thus revealing novel molecular targets that may be used to improve the efficiency of this type of treatment.
In patients with acute myeloid leukemia, cancer cells resist the effects of chemotherapy, many times resulting in disease recurrence and ultimately death.
READ MORE
 |
|
Novodiax is soon bringing to market 10-minute fast, sensitive and simple Immunoassay (IHC) kits for in vitro diagnostic use to address unmet needs in the intraoperative surgical oncology sector. Learn More
|
|
NCoBC
A breast surgeon’s goal is to eliminate cancer while achieving a cosmetic result that shows little evidence a surgical procedure had occurred. Use of oncoplastic surgery has dramatically increased nationwide over the last several years. The National Consortium of Breast Centers (NCoBC) recognizes the pivotal role of surgery in the overall management of the breast cancer patient and will be introducing an Oncoplastic Surgery Course at the NCoBC Annual Interdisciplinary Meeting in Las Vegas, Nev., March 10-11, 2018. This unique course will utilize the latest life-like models of a woman’s breasts with the ability to sew, cut and reconstruct tissue in real time. Nationally known surgeons will lecture, demonstrate and be present during the two-day, hands-on lab. Each participant will be able to both observe and perform multiple oncoplastic procedures on these models. For more information, visit the NCoBC 2018 Conference website. Early registration is suggested.
Rockefeller University Press via Science Daily
Genentech researchers have identified an enzyme that shifts pancreatic cancer cells to a more aggressive, drug-resistant state by epigenetically modifying the cells' chromatin. The study, which will be published in the Journal of Cell Biology, suggests that targeting this enzyme could make pancreatic cancer cells more vulnerable to existing therapies that currently have only limited effect against this deadly form of cancer.
READ MORE
Ecole Polytechnique Federale de Lausanne via Medical Xpress
Lung cancer is the leading cause of cancer-associated deaths. One of the most promising ways to treat it is by immunotherapy, a strategy that turns the patient's immune system against the tumor. In the past 20 years, immunotherapies have been largely based on the degree by which immune cells can infiltrate a lung tumor, which has become a major predictor of the patient's overall prognosis.
READ MORE
ACS Cancer Programs - CoC
If your program has a site visit in 2018, please note that our surveyor team has recently been notified of their assignments for the upcoming year, 2018. Over the next several weeks, you can expect to be contacted by your assigned surveyor to begin negotiating a survey date. Until then, you may find your surveyor's name in the "Facility Information" section within CoC Datalinks. We do ask that you wait for your surveyor to contact you.
READ MORE
 |
|
Donate now to help Doctors Without Borders bring emergency medical care where it is needed most. Doctors Without Borders USA relies on unrestricted donations from private donors so when an emergency strikes we assess the needs and can act fast. Donate today.
|
|
| | IMPORTANT AND DEADLINE DATES |
| Date |
Event |
Location |
| Nov. 1 |
ACS Quality and Safety Conference Abstract Submission Opened
|
|
| Jan. 10, 2018 |
Ongoing Breast Cancer Cooperative Group Clinical Trials
|
Webinar
|
| Jan. 26, 2018 |
ACS Quality and Safety Conference Abstract Submission Closes
|
|
| Feb 15, 2018 |
AJCC Staging Manual Eighth Edition Minor Rule Changes
|
Webinar (1-2 pm CT)
|
| March 20, 2018 |
AJCC Staging Manual Eighth Edition Major Rule Changes
|
Webinar (1-2 pm CT)
|
| Apr. 17, 2018 |
AJCC Staging Manual Eighth Edition CAnswer Forum and Staging Questions
|
Webinar (1-2 pm CT)
|
| July 21-24, 2018 |
ACS Quality and Safety Conference
|
Orlando
|
| July 25, 2018 |
AJCC Staging Manual Eighth Edition Head and Neck Staging
|
Webinar (1-2 pm CT)
|
| Sept. 6, 2018 |
AJCC Staging Manual Eighth Edition Breast Staging
|
Webinar (1-2 pm CT)
|
| Oct. 21-25, 2018 |
ACS Clinical Congress
|
Boston, MA
|
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The CoC and NAPBC do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons, the CoC and the NAPBC.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
